Who invested in Boston Immune Technologies & Therapeutics?
Boston Immune Technologies & Therapeutics's investors include National Institutes of Health and Hatteras Venture Partners.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$4.0Mraised across 1 round since 2024, from 1 source
Boston Immune Technologies & Therapeutics's investors include National Institutes of Health and Hatteras Venture Partners.
Boston Immune Technologies & Therapeutics has raised $4.0M across 1 round since 2024.
Boston Immune Technologies & Therapeutics's most recent round was a Grant of $4.0M in Aug 2024.
Its most recent round, $4.0M in Aug 2024, is also its largest on record.
Boston Immune Technologies & Therapeutics's first round on record, in Aug 2024, was backed by National Institutes of Health and Hatteras Venture Partners.
Boston Immune Technologies & Therapeutics's latest named round is a Grant, in Aug 2024.
Boston Immune Technologies & Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.